Status:
RECRUITING
Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease
Lead Sponsor:
Cedars-Sinai Medical Center
Conditions:
Microvascular Coronary Dysfunction
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
Microvascular coronary dysfunction (MCD) (abnormities in small blood vessels/arteries in heart) with symptoms of persistent chest pain, primarily impacts women. There are an estimated 2-3 million wome...
Eligibility Criteria
Inclusion
- Fully understanding and willing to undergo study procedures
- Male or Female greater than or equal to 18 years of age
- Understanding and willing to sign consent form.
Exclusion
- History of cardiovascular, pulmonary, or neurological disease
- Hypertension (sitting blood pressure \>140/90 mmHg, with measurements recorded on at least 2 occasions)
- Diabetes
- Unable to give informed consent;
- Contra-indication to CMRI testing, including claustrophobia and metallic implants
- Adherence or retention issues;
- Women who are pregnant.
- Allergy to animal dander.
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02301663
Start Date
November 1 2014
End Date
December 1 2030
Last Update
September 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048